Evidence map›Paper›PMID 29122983›Full record

ArticleJournal of cell science2018

Restricted cell functions on micropillars are alleviated by surface-nanocoating with amino groups.

Caroline Moerke, Susanne Staehlke, Henrike Rebl, Birgit Finke, J Barbara Nebe

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Caroline MoerkeUniversity Medical Center Rostock, Dept. of Cell Biology, Schillingallee 69, 18057 Rostock, Germany.ORCID 0000-0001-9461-2128
Susanne StaehlkeUniversity Medical Center Rostock, Dept. of Cell Biology, Schillingallee 69, 18057 Rostock, Germany.
Henrike ReblUniversity Medical Center Rostock, Dept. of Cell Biology, Schillingallee 69, 18057 Rostock, Germany.ORCID 0000-0001-6000-1724
Birgit FinkeLeibniz-Institute for Plasma Science and Technology e.V. (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany.ORCID 0000-0002-5941-0376
J Barbara NebeUniversity Medical Center Rostock, Dept. of Cell Biology, Schillingallee 69, 18057 Rostock, Germany barbara.nebe@med.uni-rostock.de.ORCID 0000-0003-2662-0905
University of Rostock · DELeibniz Institute for Plasma Science and Technology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The topographical and chemical surface features of biomaterials are sensed by the cells, affecting their physiology at the interface. When placed on titanium, we recently discovered osteoblasts attempted caveolae-mediated phagocytosis of the sharp-edged microstructures. This active, energy-consuming process resulted in decreased osteoblastic cell functions (e.g. secretion of extracellular matrix proteins). However, chemical modification with plasma polymerized allylamine (PPAAm) was able to amplify osteoblast adhesion and spreading, resulting in better implant osseointegration

Indexed as

Cell AdhesionGene ExpressionAllylamineCell LineCoated Materials, BiocompatibleCollagen Type IExtracellular Matrix ProteinsFibronectinsHumansOsteoblastsOsteocalcinPolymerizationRNA, MessengerSurface PropertiesTitaniumAllylamineCoated Materials, BiocompatibleCollagen Type IExtracellular Matrix ProteinsFibronectinsOsteocalcinRNA, MessengerTitaniumCa2+ mobilizationCell–substrate interactionMicrotopographymRNA expressionOsteoblastPlasma polymer nanocoating

Identifiers

PMID29122983
PMCPMC5818059
OpenAlexW2767787944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.